At the cellular level, expiMap identifies transcriptional and cell–cell interaction circuits with the potential to be druggable, such as RIG-I/MDA5 and annexins, to help suppress cytokine storm syndrome in patients with COVID-19, which results in hospitalization. This evidence concerns the gene RIGI and COVID-19.